Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/817,526external-prioritypatent/US4683221A/en
Application filed by Scripps Clinic ResfiledCriticalScripps Clinic Res
Publication of NO873751D0publicationCriticalpatent/NO873751D0/en
Publication of NO873751LpublicationCriticalpatent/NO873751L/en
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Micro-Organisms Or Cultivation Processes Thereof
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Lymfocytt-aktiverende poly-peptid, preparat som inneholder polypeptidet og fremgangsmåte for anvendelse av preparatet.olypeptidet inneholder en sekvens med 4 til ca. 11 rester, og tilsvarer i rekkefølge formelen: (B)-Leu-Pro-Pro-Ser-(Y)y.Lymphocyte-activating polypeptide, preparation containing the polypeptide and method of using the preparation. The polypeptide contains a sequence of 4 to about 11 residues, and corresponds in order to the formula: (B) -Leu-Pro-Pro-Ser- (Y) y.
PROCEDURE FOR PREPARING 4'-DEMETHYL-EPIPODOPHYLLOTOXIN-BETA-D-ETHYLIDENE GLYCOCIDE AND ACYLER DERIVATIVES THEREOF USED AS THE PRESENT MATERIALS OF THE PROCEDURE
HIV-1-related polypeptides, compositions comprising a mixture of at least two polypeptides, as well as diagnostic system and use of a polypeptide for the measurement of anti-HIV-1 antibodies